Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Brunelli

Showing results (341-350 of 409) with videos related to

Pageof 41
Sort By:
Cancers|June 19, 2024
Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral CenterAntonio Benito Porcaro, Alberto Bianchi, Sebastian Gallina, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 14, 2024
The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2bAntonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, et al.
The Oncologist|August 21, 2025
Interleukin-8 as a potential prognostic biomarker in Renal Cell Carcinoma: A systematic review and Meta-AnalysisFrancesca Zacchi, Sara Merler, Ilaria Zampiva, et al.
Frontiers in Immunology|August 15, 2022
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selectionEnrico Munari, Giulia Querzoli, Matteo Brunelli, et al.
International Urology and Nephrology|October 22, 2021
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancerAntonio Benito Porcaro, Sebastian Gallina, Alberto Bianchi, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 29, 2015
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell CarcinomaFrancesco Massari, Chiara Ciccarese, Emilio Bria, et al.
Pathology Oncology Research : POR|July 12, 2017
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign OutcomeFrancesco Massari, Chiara Ciccarese, Ondrej Hes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 7, 2017
Liver Metastases From Renal Oncocytoma With Vascular ExtensionGiovanni Cacciamani, Luca Cima, Miriam Ficial, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.
Expert Opinion on Therapeutic Targets|December 7, 2021
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profilesMichele Simbolo, Samantha Bersani, Caterina Vicentini, et al.
Pageof 41

Showing results (341-350 of 409) with videos related to

Sort By:
Pageof 41
Cancers|June 19, 2024
Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral CenterAntonio Benito Porcaro, Alberto Bianchi, Sebastian Gallina, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 14, 2024
The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2bAntonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, et al.
The Oncologist|August 21, 2025
Interleukin-8 as a potential prognostic biomarker in Renal Cell Carcinoma: A systematic review and Meta-AnalysisFrancesca Zacchi, Sara Merler, Ilaria Zampiva, et al.
Frontiers in Immunology|August 15, 2022
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selectionEnrico Munari, Giulia Querzoli, Matteo Brunelli, et al.
International Urology and Nephrology|October 22, 2021
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancerAntonio Benito Porcaro, Sebastian Gallina, Alberto Bianchi, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 29, 2015
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell CarcinomaFrancesco Massari, Chiara Ciccarese, Emilio Bria, et al.
Pathology Oncology Research : POR|July 12, 2017
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign OutcomeFrancesco Massari, Chiara Ciccarese, Ondrej Hes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 7, 2017
Liver Metastases From Renal Oncocytoma With Vascular ExtensionGiovanni Cacciamani, Luca Cima, Miriam Ficial, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.
Expert Opinion on Therapeutic Targets|December 7, 2021
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profilesMichele Simbolo, Samantha Bersani, Caterina Vicentini, et al.
Pageof 41